BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 5, 2011
View Archived Issues
Noninvasive method predicts organ rejection using donor DNA levels in transplant recipient's plasma
Read More
Lab-on-a-chip device SIMBAS enables quick separation of parasites from human blood
Read More
Antitumor effects of tolfenamic acid correlate with downregulation of transcription factors Sp1/3/4
Read More
Glenmark Pharma begins IND-enabling studies for GBR-401
Read More
Orexo advances development of OX-51 for pain
Read More
CPP-109 enters trial for cocaine and alcohol addiction
Read More
Astellas licenses three agents to Cardeus Pharma
Read More
America Stem Cell's ASC-101 obtains FDA orphan drug status
Read More
Novel microtubule-disrupting agents claimed
Read More
Enrollment begins in phase III EMPOWER trial of dexpramipexole in ALS
Read More
NeuroSearch patents new modulators of voltage-gated potassium channels
Read More
ISP Investments presents new protein-glutamine gamma-glutamyltransferase activator
Read More
Quest Diagnostics acquires Athena Diagnostics
Read More
Pfizer receives FDA refuse to file letter for tafamidis in TTR-FAP
Read More
Avanir Pharma files IND for AVP-923 for neuropathic pain in MS
Read More
Tibotec scientists design novel anti-HCV agents
Read More
New inhibitors of cyclin-dependent kinase 9 patented by Novartis
Read More
Pan-Akt inhibitor GDC-0068 demonstrates in vivo antitumor effects
Read More
Morphotek acquires tumor-targeting peptide platform from TransMolecular
Read More
Boston Scientific reports data on new alloy and stent design
Read More
Final SELECT-2 data show CR2b is efficacious against hepatitis C when dosed every 2 weeks
Read More
Daiichi Sanyko completes acquisition of Plexxikon
Read More
Reporting of final results of phase II AZX-100 trial to be delayed
Read More
Abstral launched in U.S. for breakthrough cancer pain
Read More